Synthesis and in vitro antibacterial activity of new oxoethylthio-1,3,4-oxadiazole derivatives

In the present investigation, a series of 2(4-pyridyl)-5[(aryl/heteroarylamino)-1-oxoethyl]thio-1,3,4-oxadiazole were synthesized using isonicotinohydrazide and substituted aryl/heteroaryl amines using pyridine as solvent. Newly synthesized compounds were tested for their in vitro anti-tubercular ac...

Full description

Bibliographic Details
Published in:Journal of Saudi Chemical Society
Main Authors: Jignesh P. Raval, Tarunkumar N. Akhaja, Dhaval M. Jaspara, Kruti N. Myangar, Nilesh H. Patel
Format: Article
Language:English
Published: Springer 2014-04-01
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1319610311001189
_version_ 1848658111607341056
author Jignesh P. Raval
Tarunkumar N. Akhaja
Dhaval M. Jaspara
Kruti N. Myangar
Nilesh H. Patel
author_facet Jignesh P. Raval
Tarunkumar N. Akhaja
Dhaval M. Jaspara
Kruti N. Myangar
Nilesh H. Patel
author_sort Jignesh P. Raval
collection DOAJ
container_title Journal of Saudi Chemical Society
description In the present investigation, a series of 2(4-pyridyl)-5[(aryl/heteroarylamino)-1-oxoethyl]thio-1,3,4-oxadiazole were synthesized using isonicotinohydrazide and substituted aryl/heteroaryl amines using pyridine as solvent. Newly synthesized compounds were tested for their in vitro anti-tubercular activity against Mycobacterium tuberculosis H37Rv using the BACTEC 460 radiometric system. Among the synthesized compounds, compounds 2(4-pyridyl)-5((2-nitrophenylamino)-1-oxoethyl)thio-1,3,4-oxadiazole (5e), 2(4-pyridyl)-5((4-nitrophenylamino)-1-oxoethyl)thio-1,3,4-oxadiazole (5g) and 2(4-pyridyl)-5((2-pyrrolylamino)-1-oxoethyl)thio-1,3,4-oxadiazole (5k) produced highest efficacy and exhibited >90% inhibition at a concentration of 0.0077, 0.0052 and 0.0089 μM, respectively. All the new compounds were pharmacologically evaluated for their in vitro Antimicrobial activity.
format Article
id doaj-art-68becb3ccba34f62b8b2518b4e4bac8d
institution Directory of Open Access Journals
issn 1319-6103
language English
publishDate 2014-04-01
publisher Springer
record_format Article
spelling doaj-art-68becb3ccba34f62b8b2518b4e4bac8d2025-11-02T11:17:19ZengSpringerJournal of Saudi Chemical Society1319-61032014-04-0118210110610.1016/j.jscs.2011.05.019Synthesis and in vitro antibacterial activity of new oxoethylthio-1,3,4-oxadiazole derivativesJignesh P. Raval0Tarunkumar N. Akhaja1Dhaval M. Jaspara2Kruti N. Myangar3Nilesh H. Patel4Department of Pharmaceutical Chemistry, Ashok & Rita Patel Institute of Integrated Study and Research in Biotechnology and Allied Sciences, New Vallabh Vidhyanagar, Anand, Gujarat 388 121, IndiaDepartment of Pharmaceutical Chemistry, Ashok & Rita Patel Institute of Integrated Study and Research in Biotechnology and Allied Sciences, New Vallabh Vidhyanagar, Anand, Gujarat 388 121, IndiaDepartment of Pharmaceutical Chemistry, Ashok & Rita Patel Institute of Integrated Study and Research in Biotechnology and Allied Sciences, New Vallabh Vidhyanagar, Anand, Gujarat 388 121, IndiaDepartment of Pharmaceutical Chemistry, Ashok & Rita Patel Institute of Integrated Study and Research in Biotechnology and Allied Sciences, New Vallabh Vidhyanagar, Anand, Gujarat 388 121, IndiaResearch Scientist, EMCURE Pharmaceuticals USA INC, 21-B Cotters In, East Brunswick, NJ 08816, USAIn the present investigation, a series of 2(4-pyridyl)-5[(aryl/heteroarylamino)-1-oxoethyl]thio-1,3,4-oxadiazole were synthesized using isonicotinohydrazide and substituted aryl/heteroaryl amines using pyridine as solvent. Newly synthesized compounds were tested for their in vitro anti-tubercular activity against Mycobacterium tuberculosis H37Rv using the BACTEC 460 radiometric system. Among the synthesized compounds, compounds 2(4-pyridyl)-5((2-nitrophenylamino)-1-oxoethyl)thio-1,3,4-oxadiazole (5e), 2(4-pyridyl)-5((4-nitrophenylamino)-1-oxoethyl)thio-1,3,4-oxadiazole (5g) and 2(4-pyridyl)-5((2-pyrrolylamino)-1-oxoethyl)thio-1,3,4-oxadiazole (5k) produced highest efficacy and exhibited >90% inhibition at a concentration of 0.0077, 0.0052 and 0.0089 μM, respectively. All the new compounds were pharmacologically evaluated for their in vitro Antimicrobial activity.http://www.sciencedirect.com/science/article/pii/S1319610311001189Isonicotinohydrazide1,3,4-oxadiazoleOxoethylthio-1,3,4-oxadiazoleAnti-tubercularMycobacterium tuberculosis
spellingShingle Jignesh P. Raval
Tarunkumar N. Akhaja
Dhaval M. Jaspara
Kruti N. Myangar
Nilesh H. Patel
Synthesis and in vitro antibacterial activity of new oxoethylthio-1,3,4-oxadiazole derivatives
Isonicotinohydrazide
1,3,4-oxadiazole
Oxoethylthio-1,3,4-oxadiazole
Anti-tubercular
Mycobacterium tuberculosis
title Synthesis and in vitro antibacterial activity of new oxoethylthio-1,3,4-oxadiazole derivatives
title_full Synthesis and in vitro antibacterial activity of new oxoethylthio-1,3,4-oxadiazole derivatives
title_fullStr Synthesis and in vitro antibacterial activity of new oxoethylthio-1,3,4-oxadiazole derivatives
title_full_unstemmed Synthesis and in vitro antibacterial activity of new oxoethylthio-1,3,4-oxadiazole derivatives
title_short Synthesis and in vitro antibacterial activity of new oxoethylthio-1,3,4-oxadiazole derivatives
title_sort synthesis and in vitro antibacterial activity of new oxoethylthio 1 3 4 oxadiazole derivatives
topic Isonicotinohydrazide
1,3,4-oxadiazole
Oxoethylthio-1,3,4-oxadiazole
Anti-tubercular
Mycobacterium tuberculosis
url http://www.sciencedirect.com/science/article/pii/S1319610311001189
work_keys_str_mv AT jigneshpraval synthesisandinvitroantibacterialactivityofnewoxoethylthio134oxadiazolederivatives
AT tarunkumarnakhaja synthesisandinvitroantibacterialactivityofnewoxoethylthio134oxadiazolederivatives
AT dhavalmjaspara synthesisandinvitroantibacterialactivityofnewoxoethylthio134oxadiazolederivatives
AT krutinmyangar synthesisandinvitroantibacterialactivityofnewoxoethylthio134oxadiazolederivatives
AT nileshhpatel synthesisandinvitroantibacterialactivityofnewoxoethylthio134oxadiazolederivatives